A transient intermediate RNA structure underlies the regulatory function of theE. coli thiBTPP translational riboswitch

Abstract

Riboswitches are cis-regulatory RNA elements that regulate gene expression in response to ligand binding through the coordinated action of a ligand-binding aptamer domain (AD) and a downstream expression platform (EP). Previous studies of transcriptional riboswitches have uncovered diverse examples that utilize structural intermediates that compete with the AD and EP folds to mediate the switching mechanism on the timescale of transcription. Here we investigate whether similar intermediates are important for riboswitches that control translation by studying the Escherichia coli thiB thiamine pyrophosphate (TPP) riboswitch. Using cellular gene expression assays, we first confirmed that the riboswitch acts at the level of translational regulation. Deletion mutagenesis showed the importance of the AD-EP linker sequence for riboswitch function. Sequence complementarity between the linker region and the AD P1 stem suggested the possibility of an intermediate nascent RNA structure called the anti-sequestering stem that could mediates the thiB switching mechanism. Experimentally informed secondary structure models of the thiB folding pathway generated from chemical probing of nascent thiB structures in stalled transcription elongation complexes confirmed the presence of the anti-sequestering stem, and showed it may form cotranscriptionally. Additional mutational analysis showed that mutations to the anti-sequestering stem break or bias thiB function according to whether the anti-sequestering stem, or P1 is favored. This work provides an important example of intermediate structures that compete with AD and EP folds to implement riboswitch mechanisms.

Kinetic pathway of HIV-1 TAR cotranscriptional folding

“…As a result, these TAR cotranscriptional folding intermediates could potentially serve as drug targets that are previously overlooked and underestimated. Future directions involve using methods such as NMR to capture the high-resolution three-dimensional structures of RNAs along the cotranscriptional folding pathway and screening drug molecules targeting the RNA structures ( 46 , 77 ).…”